In recent times, the incidence of oral diseases has witnessed an alarming upsurge. Unhealthy lifestyles, rise in tobacco intake, and humble awareness about the severity of oral ailments have increased the prevalence of chronic oral diseases such as mouth ulcers. Moreover, growing number of patients with Behçet’s disease, Crohn’s diseases, systemic lupus erythematosus, and ulcerative colitis have dramatically increased the incidence of mouth ulcers. In this context, the demand for efficient, effective, and advanced mouth ulcer treatments has grown substantially. Both patients and healthcare professionals (HCPs) are seeking treatments that aid in comprehensive diagnosis and treatment of mouth ulcers. These trends are poised to positively influence the expansion of the global mouth ulcers treatment market, creating headways for novel partnerships and medical innovation.
Fairfield Market Research finds that the global mouth ulcers treatment market is expected to reach a total market valuation of US$ 2,047.9 million by 2026, registering a promising CAGR of 3.9%. Compared to the total market value of 2021, which stood at US$ 1,690.6 million, the projected market valuation is a robust indicator of the lucrative opportunities present in the mouth ulcers treatment market. This strong economic potential of the market is expected to influence favorable merger & acquisitions, business ventures, and product innovation.
To Read Complete Report of Mouth Ulcers Treatment Market: https://www.fairfieldmarketresearch.com/report/mouth-ulcer-treatment-market
Rising Incidence of Severe Mouth Ulcers to Soar Demand for Advanced Treatments
Rapidly rising cases of mouth ulcers among COVID-19 positive patients, cancer patients and survivors, and people with high-risk comorbidities have surged the demand for mouth ulcer treatments. This has propelled the healthcare community, particularly dermatologists and dentists, to invest greater resources toward rigorous R&D within the mouth ulcers treatment market. Against this medical landscape, the global mouth ulcers treatment market is on a promising growth trajectory. During the forecast period, greater consumer demand for over-the-counter medicines and HCPs’ strong commitments toward drug discovery are projected to unlock fruitful business opportunities in the mouth ulcers treatment market. Notably, on the basis of drug class, Analgesics and Corticosteroids are forecast to register the highest CAGR of 4.3% over the assessment period. Further, as per indication, Aphthous Stomatitis is anticipated to dominate in terms of revenue generation, recording a market value of US$ 1,072.3 million by 2026.
Presence of Robust Healthcare Facilities Enable North America to Sustain Market Lead
North America is projected to maintain its lead in the global mouth ulcers treatment market. In 2021, it commanded an overall market value of US$ 517.9 million – this market valuation is set to reach US$ 603.5 million by 2026, growing at a CAGR of 3.1%. Over the forecast period, the presence of prominent market players, coupled with sound awareness about and availability of advanced medical treatments, North America’s mouth ulcers treatment market is on route to phenomenal expansion. On the other hand, the Asia Pacific is predicted to demonstrate a higher CAGR of 4.7% between 2021-2026. Emerging economies in APAC such as India, Japan, and China are expected to immensely contribute toward this sound growth. Factors such as a rapidly growing geriatric population and greater demand for oral care products are projected to lead market expansion in the Asia Pacific.
Key players in the global mouth ulcers treatment market include Pfizer, Inc., Bristol-Myers Squibb Company, Colgate-Palmolive Company, Patterson Companies, Inc., Blistex Inc., Dr. Reddy’s Laboratories Ltd, Church & Dwight Co., Inc., and GlaxoSmithKline plc.
For More Information: https://www.fairfieldmarketresearch.com/report/mouth-ulcer-treatment-market
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
